Seeking Alpha

ccot's  Instablog

ccot
Send Message
I promote good science through my due diligence skills.
  • CEL-SCI Phase 3 Trial To Continue In Taiwan 1 comment
    Apr 12, 2012 11:53 PM | about stocks: CVM

    During February 2012, CCH Hospital's Institutional Review Board (IRB) reviewed and voted during an monthly meeting on whether the clinical trials that were ongoing in the hospital were worthy of being re-approved to be continued for another year. One of the clinical trials that came under an annual review was CEL-SCI's Multikine head and neck cancer drug. The results of the review were; 6 votes to continue, 0 votes to suspend, and 0 votes to terminate. In August 2011, the Northern Mississippi Health System's IRB also voted to renew the Multikine phase 3 clinical trial.

    On an annual basis hospital IRB's review interim reports to determine whether the trial is providing a benefit to patients and if it should continue , be suspended pending further review, or if doing harm to patients, be terminated.

    As little news of the Multikine phase 3 trial's enrollment numbers or interim results are flowing from CEL-SCI's management, it's the little tidbits from the IRB's that are giving CEL-SCI investors hope that they may have backed the right horse in the biotech race.

    Sources: http://www.nmhs.net/physicians_portal/documents/sept2011practicenotes.pdf

    http://www2.cch.org.tw/IRB/data/2012%E5%B9%B4%E7%AC%AC2%E6%AC%A1%E7%AC%AC%E4%B8%89IRB%E6%9C%83%E8%AD%B0%E8%A8%98%E9%8C%8420120223(%E7%B6%B2%E9%A0%81%E5%85%AC%E5%91%8A%E7%89%88).pdf

    Translation: Google Translate

    Source Disclaimer: This information in this article is based on the NMHS September 2011 Practice Notes, CCH Hospital's February 2012 IRB Bulletin and the Google Translate online tool. No assurance is placed by the author over the accuracy or completeness of the hospital updates or the Google Translate tool.

    Disclosure: I am long CVM.

Back To ccot's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (1)
Track new comments
  • going%20forward
    , contributor
    Comments (14) | Send Message
     
    coming great news soon hang on
    18 Oct 2012, 11:00 AM Reply Like
Full index of posts »
Latest Followers

Latest Comments


Most Commented
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.